Scion BioMedical (formerly Halosource Biomedical) is a company developing solutions for wound care, hemostasis, and healing. It offers Clo-Sur P.A.D. and Clo-SurPLUS P.A.D.1, composed of the material known as polyprolate and designed to accelerate the control of bleeding in catheterization and other interventional and invasive procedures. The company caters to hospitals, ambulatory surgery centers, outpatient care, physician offices, emergency care, nursing homes, etc.